Hyperfibrinolysis Increases the Risk of Gastrointestinal Hemorrhage in Patients With Advanced Cirrhosis
Open Access
- 1 April 1992
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 15 (4) , 672-676
- https://doi.org/10.1002/hep.1840150420
Abstract
Sixty–one patients with different degrees of liver failure, 23 with Child–Pugh class B and 38 with Child–Pugh class C, were studied and observed for 3 yr. Coagulation index analysis showed significantly lower values of prothrombin activity, more prolonged activated partial thromboplastin time, higher bilirubin and fibrinogen degradation products values in class C patients. Among all patients, 28 had fibrinogen degradation products values greater than 10 μg/ml, and in these patients a hyperfibrinolytic state was confirmed by higher values of circulating plasminogen activator antigen (17.3 ± 8.7 ng/ml vs. 5.41 ± 1.9 ng/ml; p < 0.0001) and activity (6.6 ± 2.1 IU/ml vs. 1.92 ± 1.12 IU/mi; p < 0.0001) and significantly lower plasminogen activator inhibitor antigen (6.4 ± 3.5 ng/ml vs. 15.8 ± 5.6 ng/ml; p < 0.0001) and activity (3.6 ± 2.2 IU/ml vs. 8.5 ± 3.9 IU/ml; p < 0.0001). Patients with positive fibrinogen degradation products had higher serum bilirubin (6 ± 4 mg/dl vs. 2 ± 2 mg/dl; p < 0.0001) and lower fibrinogen (156 ± 52 mg/dl vs. 194 ± 62 mg/dl; p < 0.02) than patients without hyperfibrinolysis. During the follow–up period, 41 patients died, 22 from fatal gastrointestinal hemorrhage and 19 from liver failure. Thirty patients experienced fatal (22 patients) and nonfatal (8 patients) gastrointestinal hemorrhage. Patients with positive fibrinogen degradation products or class C had a higher risk of gastrointestinal bleeding than patients with negative fibrinogen degradation products (odds ratio = 8) or class B (odds ratio = 3.5), respectively. Cox's multiple regression model showed that positive fibrinogen degradation products was the best bleeding predictor (β coefficient = 3.9 ± 0.7 S.E.M., p < 0.001). This study indicates that in cirrhosis the presence of hyperfibrinolysis should be regarded as an important warning sign of gastrointestinal bleeding. (Hepatology 1992;15:672-676).Keywords
This publication has 34 references indexed in Scilit:
- Prediction of the First Variceal Hemorrhage in Patients with Cirrhosis of the Liver and Esophageal VaricesNew England Journal of Medicine, 1988
- Haemostatic problems in liver disease.Gut, 1986
- Sandwich ELISA for t-PA antigen employing a monoclonal antibodyThrombosis Research, 1986
- Laboratory tests and diagnostic procedures in evaluation of liver diseaseThe American Journal of Medicine, 1985
- Bleeding and Coagulation Abnormalities in Alcoholic Cirrhotic Liver DiseaseAlcohol, Clinical and Experimental Research, 1982
- Chronic Myelogenous Leukaemia in Infancy and Childhood: A.10-Year Study at New Delhi, IndiaActa Haematologica, 1981
- Acute upper-gastrointestinal hemorrhage new observations on an old problemDigestive Diseases and Sciences, 1978
- UPPER GASTROINTESTINAL HÆMORRHAGE IN HEPATIC CIRRHOSIS: CAUSES AND RELATION TO HEPATIC FAILURE AND STRESSThe Lancet, 1977
- Upper gastrointestinal bleeding in cirrhosis: clinical and endoscopic correlations.Gut, 1976
- Gerinnungsphysiologische Schnellmethode zur Bestimmung des FibrinogensActa Haematologica, 1957